¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-11
±³À°ÀÏÀÚ : 2020-11-11
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : À庴ȣ 
¿¬¶ôó : 02-326-0370  
À̸ÞÀÏ : head@kosphar.org      
±³À°Á¾·ù : ¾à¸®ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 220,000¿ø      
ºñ°í ÆòÀÇ¿ø, Á¤È¸¿ø: 150,000¿ø ÁØȸ¿ø: 80,000¿ø,ºñȸ¿ø: 220,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11¿ù 11ÀÏ  12:00~13:30 µî·Ï  () 
±âŸ 11¿ù 11ÀÏ  13:30~13:40 °³È¸½Ä  () 
±âŸ 11¿ù 11ÀÏ  13:40~14:40 Çмú»ó ¼ö»ó °­¿¬  () 
±³À°½Ã°£ 11¿ù 11ÀÏ  14:40~15:30 Novel Biological Functions of Lymphatic Vessels  °í±Ô¿µ(KAIST/IBS) 
È޽Ġ11¿ù 11ÀÏ  15:30~15:50 Coffee Break  () 
±³À°½Ã°£ 11¿ù 11ÀÏ  15:50~16:10 Importance of Metabolic Reprogramming in Cardiac Regeneration  ÀÌÀαÔ(°æºÏ´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:10~16:30 Statin increases hepatic gluconeogenesis through suppressing sirtuin 6 expression  ¹Úº´Çö(ÀüºÏ´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:30~16:50 Sox17 deficiency promotes pulmonary arterial hypertension  ±èÀÎÁØ(KAIST) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:50~17:10 Phospholipase C-b3 is dispensable for vasoconstriction but necessary for vascular hyperplasia  ¹è¼ø½Ä(ºÎ»ê´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  15:50~16:10 Highlighted STAT3 as a potential drug target for cancer and tumor microenvironment  ¿¹»ó±Ô(¼­¿ï´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:10~16:30 Molecular motor MYO1D anchors EGFR family to plasma membrane before their activation  ±è°æ±Ù(Àü³²´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:30~16:50 Innovative small chemicals targeting tumor microenvironment  ÀÌ°æ(µ¿±¹´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 11ÀÏ  16:50~17:10 ''''Hepatic-immune cell cross Talk'''': HDAC6 suppresses &quotDon''''t eat me  ³²¼®¿ì(°¡Å縯 ÀÇ´ë) 
Åä·Ð 11¿ù 11ÀÏ  17:10~17:30 ÁúÀÇ ¹× ÀÀ´ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2020³â Á¦64Â÷ ´ëÇÑÁ÷¾÷ȯ°æÀÇÇÐȸ °¡À»Çмú´ëȸ Àӻ󿬼ö°­Á : 2020-11-12
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ÃæûÁöȸ 11¿ù ¿ù·ÊÁý´ãȸ : 2020-11-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 18 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 9 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 9 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 8 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 9 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 6 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 4 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 6 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 9 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 6 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 8 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 8 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 4 2024-06-19
21107 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 ºñ´¢»ý½Ä¿µ»óÀÇÇÐ ¿¬¼ö°­Á : 2024-07-07 0 9 2024-06-19
21106 ¼­¿ï 2024³â Çϰ迬¼ö°­Á ¹× Á¦1ȸ ¿¹¹æÁ¢Á¾ ½ÉÆ÷Áö¾ö : 2024-07-07 0 13 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷